{"id":"https://openalex.org/W4310103495","doi":"https://doi.org/10.1182/blood-2022-170887","title":"Clonal Hematopoiesis Prevalence and Mutational Spectrum in Patients with Plasma Cell Disorders at the Time of Diagnosis and Its Impact on Clinical Features, Cardiovascular Complications, and Survival","display_name":"Clonal Hematopoiesis Prevalence and Mutational Spectrum in Patients with Plasma Cell Disorders at the Time of Diagnosis and Its Impact on Clinical Features, Cardiovascular Complications, and Survival","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310103495","doi":"https://doi.org/10.1182/blood-2022-170887"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-170887","doi":"https://doi.org/10.1182/blood-2022-170887","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-170887","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047181107","display_name":"Srinivasa Reddy Sanikommu","orcid":"https://orcid.org/0000-0002-9681-0483","observed_orcids":["https://orcid.org/0000-0002-9681-0483"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srinivasa Reddy Sanikommu","raw_affiliation_strings":["1Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, CHARLOTTE, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, CHARLOTTE, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042487436","display_name":"Shebli Atrash","orcid":"https://orcid.org/0000-0003-4547-7534","observed_orcids":["https://orcid.org/0000-0003-4547-7534"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shebli Atrash","raw_affiliation_strings":["2Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080870057","display_name":"Myra M Robinson","orcid":"https://orcid.org/0000-0002-6933-889X","observed_orcids":["https://orcid.org/0000-0002-6933-889X"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Myra Robinson","raw_affiliation_strings":["3Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000591015","display_name":"Nury Steuerwald","orcid":"https://orcid.org/0000-0002-7323-7637","observed_orcids":["https://orcid.org/0000-0002-7323-7637"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nury M. Steuerwald","raw_affiliation_strings":["4Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016465712","display_name":"Kristen Cassetta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristen Cassetta","raw_affiliation_strings":["3Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053912961","display_name":"Hsih\u2010Te Yang","orcid":"https://orcid.org/0000-0002-4851-1374","observed_orcids":["https://orcid.org/0000-0002-4851-1374"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hsih-Te Yang","raw_affiliation_strings":["5Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009378735","display_name":"Saad Z. Usmani","orcid":"https://orcid.org/0000-0002-5484-8731","observed_orcids":["https://orcid.org/0000-0002-5484-8731"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saad Usmani","raw_affiliation_strings":["6Levine Cancer Institute, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Levine Cancer Institute, New York, NY","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018065917","display_name":"Edward Alan Copelan","orcid":"https://orcid.org/0000-0001-5315-5282","observed_orcids":["https://orcid.org/0000-0001-5315-5282"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward A. Copelan","raw_affiliation_strings":["2Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069014112","display_name":"Belinda Rene Avalos","orcid":"https://orcid.org/0000-0002-2593-899X","observed_orcids":["https://orcid.org/0000-0002-2593-899X"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Belinda R. Avalos","raw_affiliation_strings":["2Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063531559","display_name":"Lawrence J. Druhan","orcid":"https://orcid.org/0000-0002-2019-2252","observed_orcids":["https://orcid.org/0000-0002-2019-2252"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence J. Druhan","raw_affiliation_strings":["2Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.23123594,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"140","issue":"Supplement 1","first_page":"11416","last_page":"11417"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clonal-hematopoiesis","display_name":"clonal hematopoiesis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/plasma-cell-dyscrasia","display_name":"plasma cell dyscrasia","score":0.984000027179718},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.746999979019165},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.8519999980926514},{"id":"https://openalex.org/keywords/mutation-spectrum","display_name":"mutation spectrum","score":0.7099999785423279},{"id":"https://openalex.org/keywords/ppm1d","display_name":"PPM1D","score":0.7459999918937683},{"id":"https://openalex.org/keywords/gnas","display_name":"GNAS","score":0.9610000252723694},{"id":"https://openalex.org/keywords/cardiovascular-comorbidity","display_name":"cardiovascular comorbidity","score":0.8069999814033508},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7480000257492065},{"id":"https://openalex.org/keywords/newly-diagnosed-multiple-myeloma","display_name":"newly diagnosed multiple myeloma","score":0.6600000262260437},{"id":"https://openalex.org/keywords/smoldering-multiple-myeloma","display_name":"smoldering multiple myeloma","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4961410462856293},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.47467970848083496},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40977126359939575},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36740991473197937},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33971983194351196},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33883795142173767},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33606141805648804},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.32352620363235474},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2664335370063782}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-170887","doi":"https://doi.org/10.1182/blood-2022-170887","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-170887","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2079838338","https://openalex.org/W2076802652","https://openalex.org/W1991432514","https://openalex.org/W2784395700","https://openalex.org/W2018552733","https://openalex.org/W4298132542","https://openalex.org/W2015726247","https://openalex.org/W2045505363","https://openalex.org/W2592615787","https://openalex.org/W3012964845"],"abstract_inverted_index":{"Introduction:":[0],"Multiple":[1],"myeloma":[2,147],"(MM)":[3],"most":[4,357],"commonly":[5],"occurs":[6],"in":[7,28,37,50,68,94,115,128,142,165,208,329,399,407,425,430,438,451,460,464,469,474,504,537,545,555,558,565,611,619,626,633,637,651,677,690,699],"older":[8,30,116,634],"individuals":[9,29],"with":[10,23,25,39,65,76,100,118,182,190,221,297,303,310,318,422,527,539,560,573,643,654,671,702],"median":[11,119,574],"age":[12,24,120,392,514,620],"at":[13,55,171,202,393],"diagnosis":[14,103,175,203,285,320],"of":[15,52,58,126,140,168,174,180,237,250,321,332,344,414,485,531,577,608,648],"70":[16,397],"years.":[17],"Clonal":[18],"hematopoiesis":[19],"(CH)":[20],"also":[21],"increases":[22],"10-15%":[26],"prevalence":[27,98,125,139,164,349,476,484,499,647,701],"than":[31,440],"70.":[32],"CH":[33,49,62,91,124,141,163,181,326,348,359,389,401,410,415,434,475,486,498,540,547,561,568,588,609,625,649,668,688,700],"has":[34],"been":[35,154],"analyzed":[36],"patients":[38,54,96,130,170,386,506,510,538,559,566,613,635,653,689],"plasma":[40],"cell":[41],"disorders":[42],"(PCD).":[43],"A":[44,673],"single":[45],"institution":[46],"study":[47,114,160],"detected":[48,93],"21.6%":[51],"MM":[53,89,452,505,571,692],"the":[56,172,178,209,273,400,408,551,587,646,691,707,714],"time":[57,101,173],"autologous":[59],"transplant":[60],"and":[61,97,149,176,185,232,264,283,299,301,373,384,448,466,515,550,590,601,636,675],"was":[63,92,252,308,327,396,416,435,479,500,534,553,582,614,630,640,669,683],"associated":[64,220,621,642,670],"poor":[66],"survival":[67,307,581,682],"those":[69],"that":[70,617],"did":[71],"not":[72,153,417,583,641,684],"receive":[73],"maintenance":[74],"therapy":[75],"immunomodulatory":[77],"drug":[78],"(IMiD)":[79],"(Mouhieddine":[80,104],"et":[81,105,133],"al,":[82,106,134],"Nat.":[83],"Comm.,":[84],"2020).":[85],"In":[86,240],"newly":[87],"diagnosed":[88,189],"patients,":[90,453,572,679],"10.2%":[95],"increased":[99,350,487,650],"from":[102,492],"Blood,":[107],"2021,":[108],"S1).":[109],"More":[110],"recently,":[111],"a":[112,159,166,235,319,322],"population-based":[113],"adults":[117],"91":[121],"yrs":[122,398,406],"showed":[123,524],"9.7%":[127],"MGUS":[129,465,493,509,658],"(Da":[131],"Via":[132],"Blood":[135],"advances,":[136],"2022).":[137],"The":[138,356,472,483,529,606],"other":[143],"PCDs":[144],"including":[145],"smoldering":[146],"(SM),":[148],"Amyloidosis":[150],"(AM)":[151],"have":[152],"reported.":[155],"We":[156,211],"therefore":[157],"conducted":[158],"to":[161,194,217,242,289,351,404,457,494,496,508,542,616,659,661,712],"identify":[162,218,290],"spectrum":[167,607],"PCD":[169,191,323,490,612,628,652,678,703],"examined":[177],"association":[179,526],"clinical":[183],"features":[184],"outcomes.":[186],"Methods:":[187],"Patients":[188],"who":[192,198],"consented":[193],"our":[195,627],"biorepository":[196],"protocol":[197],"had":[199,378,382,387],"samples":[200],"collected":[201],"were":[204,262,267,270,287,295,324,362],"eligible":[205],"for":[206,234,258,513,598,666,687,709],"inclusion":[207],"study.":[210],"performed":[212],"next":[213],"generation":[214],"sequencing":[215],"(NGS)":[216],"mutations":[219,610],"myeloid":[222],"neoplasm":[223],"using":[224,272,334],"Archer":[225,274],"Core":[226],"Myeloid":[227],"VarientPlex":[228],"panel":[229],"plus":[230],"PPM1D":[231,374],"GNAS":[233],"total":[236],"39":[238],"genes.":[239],"order":[241],"detect":[243],"very":[244],"low":[245],"frequency":[246,338],"variants,":[247],"250":[248],"ng":[249],"DNA":[251],"used":[253,288],"as":[254,489],"input,":[255],"cycling":[256],"conditions":[257],"both":[259],"PCR":[260],"steps":[261],"modified,":[263],"15-20M":[265],"reads/sample":[266],"targeted.":[268],"Variants":[269],"called":[271],"Analysis":[275],"Bioinformatics":[276],"Suite":[277],"variant":[278,336],"calling":[279],"pipeline.":[280],"ICD":[281],"9":[282],"10":[284],"codes":[286],"cardiovascular":[291,521],"comorbidities.":[292],"Categorical":[293],"outcomes":[294],"summarized":[296],"frequencies":[298],"proportions":[300],"modeled":[302],"logistic":[304],"regression.":[305,314],"Overall":[306],"evaluated":[309],"Cox":[311],"proportional":[312],"hazards":[313],"Results:":[315],"228":[316],"subjects":[317,333],"included.":[325],"identified":[328,361],"10.5%":[330],"(24/228)":[331],"2%":[335],"alle":[337],"(VAF).":[339],"When":[340],"we":[341],"included":[342],"VAF":[343],"1%":[345],"or":[346],"greater,":[347],"17.5%":[352],"(40/228,":[353],"Figure":[354,717],"1A).":[355],"common":[358,437],"clones":[360],"DNMT3A":[363],"(24),":[364],"TET2":[365],"(8),":[366],"KRAS":[367],"(4),":[368],"U2AF1":[369],"(2),":[370,372],"TP53":[371],"(2).":[375],"30":[376],"pts":[377,548],"1":[379],"mutation,":[380],"8":[381],"2,":[383],"2":[385],"3":[388],"clones.":[390],"Median":[391],"sample":[394],"collection":[395],"group":[402,411,589,592],"compared":[403,456,507,541],"63":[405],"no":[409,546],"(p<.001.)":[412],"Prevalence":[413],"significantly":[418,480,584,685],"different":[419,481,585,686],"among":[420],"races":[421],"18.5%":[423],"(29/157)":[424],"Caucasians":[426],"vs":[427,444,562],"15.4%":[428],"(10/65)":[429],"Africans":[431],"Americans":[432],"(p=.87).":[433],"more":[436,449,631,672],"males":[439,638],"females":[441],"[22.3%":[442],"(25/112)":[443],"12.9%":[445],"(15/106)":[446],"p=.08]":[447],"prevalent":[450,632],"27.5%":[454],"(25/91),":[455],"14.6%":[458],"(8/55)":[459],"SM,":[461],"9.5%":[462],"(6/63)":[463],"5.3%":[467],"(1/19)":[468],"AM":[470],"patients.":[471],"difference":[473],"by":[477],"Dx":[478],"(p=.012).":[482],"linearly":[488],"progressed":[491],"SM":[495,660],"MM.":[497],"4.5":[501],"times":[502],"higher":[503],"after":[511],"adjusting":[512],"gender":[516],"(Figure":[517],"1B).":[518],"Evaluating":[519],"several":[520],"comorbidities,":[522],"two":[523],"significant":[525],"CH.":[528,622],"rate":[530],"atrial":[532],"fibrillation":[533],"30%":[535],"(12/40)":[536],"15%":[543],"(28/188)":[544],"(p=0.037),":[549],"atherosclerosis":[552,676],"reported":[554],"20%":[556],"(8/40)":[557],"8%":[563],"(15/188)":[564],"without":[567],"(p=0.038).":[569],"Among":[570],"follow":[575],"up":[576],"45.5":[578],"mo,":[579],"overall":[580,681],"between":[586],"no-CH":[591],"[HR":[593],"0.65":[594],"(0.17-2.55,":[595],"p=.54),":[596],"adjusted":[597,665],"age,":[599],"gender,":[600],"cytogenetic":[602],"risk":[603],"level].":[604],"Conclusion:":[605],"similar":[615],"found":[618],"As":[623],"expected,":[624],"population":[629],"but":[639,680],"race.":[644],"Notably,":[645],"increasing":[655],"disease":[656,704],"severity,":[657],"MM,":[662],"even":[663],"when":[664],"age.":[667],"Fib":[674],"subgroup.":[693],"Our":[694],"data":[695],"indicate":[696],"an":[697],"increase":[698],"progression":[705],"highlighting":[706],"need":[708],"additional":[710],"studies":[711],"evaluate":[713],"factors":[715],"responsible.":[716],"1View":[718,721],"largeDownload":[719,722],"PPTFigure":[720],"PPT":[723],"Close":[724],"modal":[725]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-10T00:00:00"}